The human hair follicle immune system: Cellular composition and immune privilege

British Journal of Dermatology

Volumn 142, Issue 5, 2000, Pages 862-873

  Christoph, T ^b   Muller Rover S ^b,e   Audring, H ^b   Tobin, D J ^f   Hermes, B ^b,c   Cotsarelis, G ^d   Ruckert R ^b   Paus, Ralf ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

CD1a; CD4; CD68; CD8; Cutaneous immunity; Hair follicle; Major histocompatability complex class II; Major histocompatibility complex class I

Indexed keywords

BETA 2 MICROGLOBULIN; CD20 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; FAS ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALOPECIA AREATA; ARTICLE; B LYMPHOCYTE; HAIR DISEASE; HAIR FOLLICLE; HAIR GROWTH; HUMAN; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; KERATINOCYTE; LANGERHANS CELL; MACROPHAGE; MAST CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TRANSMISSION ELECTRON MICROSCOPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; ANTIGENS, CD95; B-LYMPHOCYTES; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HAIR FOLLICLE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; INTERCELLULAR ADHESION MOLECULE-1; KERATINOCYTES; KILLER CELLS, NATURAL; LANGERHANS CELLS; MACROPHAGES; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELLS; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SEBACEOUS GLANDS; SKIN; T-LYMPHOCYTES;

EID: 0005024567     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03464.x     Document Type: Article

References (63)

1. 1 Paus R, Eichmüller S, Hofmann U et al. Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol 1994; 131: 177-83.
2. 2 Paus R, Hofmann U, Eichmüller S, Czarnetzki BM. Distribution and changing density of gamma-delta T cells in murine skin during the induced hair cycle. Br J Dermatol 1994; 130: 281-9.
3. 3 Paus R, van der Veen C, Eichmüller S et al. Generation and cyclic remodeling of the hair follicle immune system in mice. J Invest Dermatol 1998; 111: 7-18.
4. 4 Rückert R, Hofmann U, van der Veen C et al. MHC class I expression in murine skin: developmentally controlled and strikingly restricted intraepithelial expression during hair follicle morphogenesis and cycling, and response to cytokine treatment in vivo. J Invest Dermatol 1998; 111: 25-30.
5. 5 Janeway CA, Travers P. Immunobiology. 3rd edn. London: Current Biology, 1997.
6. 6 Billingham RE, Silvers WK. A biologist's reflections on dermatology. J Invest Dermatol 1971; 57: 227-40.
7. 7 Westgate GE, Craggs RI, Gibson WT. Immune privilege in hair growth. J Invest Dermatol 1991; 97: 417-20.
8. 8 Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I-expression in the anagen hair bulb? Yale J Biol Med 1994; 66: 541-54.
9. 9 Becker JC, Varki N, Brocker EB, Reisfeld RA. Lymphocyte-mediated alopecia in C57BL/6 mice following successful immuno-therapy for melanoma. J Invest Dermatol 1996; 107: 627-32.
10. 10 Eichmüller S, van der Veen C, Moll I et al. Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion. J Histochem Cytochem 1998; 46: 361-70.
11. 11 Hermes B, Paus R. 'Vernarbende' Alopezien. Anmerkungen zur Qualifikation, Differentialdiagnose und Pathobiologie. Hautarzt 1998; 49: 462-72.
12. 12 Paus R, Christoph T, Müller-Röver S. Immunology of the hair follicle: a short journey into terra incognita. J Invest Dermatol Symp Proc 1999; 4: 226-34.
13. 13 Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol 1992; 127: 239-46.
14. 14 Harrist TJ, Ruiter DJ, Mihm Mc Jr, Bhan AK. Distribution of major histocompatibility antigens in normal skin. Br J Dermatol 1983: 109: 623-33.
15. 15 Bröcker EB, Echternacht Happle K, Hamm H, Happle R. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 1987; 88: 564-8.
16. 16 Khoury EL, Price VH, Greenspan JS. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. J Invest Dermatol 1988; 90: 193-200.
17. 17 Hashimoto K, Shibatzi S. Ultrastructural study on the differentiation and function of hair. In: Biology and Disease of the Hair (Kobori T, Montagna W, eds). Baltimore: University Park Press, 1976:23.
18. 18 Moresi JM, Horn TD. Distribution of Langerhans cells in human hair follicle. J Cutan Pathol 1997; 24: 636-40.
19. 19 Gilliam AC, Kremer IB, Yoshida Y et al. The human hair follicle: a reservoir of CD40+ B7-deficient Langerhans cells that repopulate epidermis after UVB exposure. J Invest Dermatol 1998; 110: 422-7.
20. 20 Kligman AM. The human hair cycle. J Invest Dermatol 1959; 33: 307-16.
21. 21 Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
22. 22 Kuhlmann WD, Peschke P. Commercial polyclonal and monoclonal histostaining PAP kits. Immunoperoxidase reagents and performance characteristics in comparison with self-prepared immunoreagents. Histochemistry 1985; 82: 411-19.
23. 23 Tobin DJ. Morphologic analysis of hair follicles in acute alopecia areata. Microscopy Res Technique 1997; 38: 443-51.
24. 24 Bos JD (ed.). The Skin Immune System. Boca Raton: CRC Press, 1997.
25. 25 Smith ME, Holgate CS, Williamson JM et al. Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma. J Clin Pathol 1987; 40: 34-41.
26. 26 Elder D (ed.) Lever's Histopathology of the Skin, 8th edn. Philadelphia: Lippinscott-Raven, 1997.
27. 27 Falini B, Flenghi L, Pileri S et al. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am J Pathol 1993; 142: 1359-72.
28. 28 Ledbetter JA, Evans RL, Lipinski M et al. Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/ inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med 1981; 153: 310-23.
29. 29 Gielen V, Schmitt D, Thivolet J. HLA class I antigen (heavy and light chain) expression by Langerhans cells and keratinocytes of the normal human epidermis: ultrastructural quantitation using immunogold labelling procedure. Arch Dermatol Res 1988; 280: 131-6.
30. 30 Brent L. The discovery of immunologic tolerance. Hum Immunol 1997; 52: 75-81.
31. 31 Uckan D, Steele A, Cherry et al. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod 1997; 3: 655-62.
32. 32 Streilein JW. Unraveling immune privilege. Science 1995; 270: 1158-9.
33. 33 Griffith TS, Brunner T, Fletcher SM et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-92.
34. 34 Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-43.
35. 35 Ishii Y, Takami T, Yuasa H et al. Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies. Clin Exp Immunol 1984; 58: 183-92.
36. 36 Davodeau F, Houde I, Boulot G et al. Secretion of disulfide-linked human T-cell receptor gamma delta heterodimers. J Biol Chem 1993; 268: 15455-60.
37. 37 Kaserer K, Exner M, Mosberger I et al. Characterization of the inflammatory infiltrate in autoimmune cholangitis. A morphological and immunhistochemical study. Virchows Arch 1998; 432: 217-22.
38. 38 Merlio JP, Caveriviere P, al Saati T et al. Cells of the phenotype HNK-1 + (CD 57+) in reactive adenopathies, lymphomas and Hodgkin's disease. Ann Pathol 1990; 10: 166-73.
39. 39 Maurer M, Paus R, Czarnetzki BM. Mast cells as modulators of hair follicle cycling. Exp Dermatol 1995; 4: 266-71.
40. 40 Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237-44.
41. 41 Raulet DH. Does a low level of expression of HLA molecules engender autoimmunity? N Engl J Med 1999; 340: 314-15.
42. 42 Nakajima M, Nakajima A, Kayagaki N et al. Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury. Clin Immunol Immunopathol 1997; 83: 223-9.
43. 43 Paus R. Immunology of the hair follicle. In: The Skin Immune System (Bos JD, ed.). Boca Raton: CRC Press, 1997: 377-98.
44. 44 Gruschwitz M, Muller PU, Sepp N et al. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 1990; 94: 197-203.
45. 45 Schmid P, Itin P, Rufli T. In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas. Br J Dermatol 1996; 134: 1044-51.
46. 46 Slominski A, Wortsman J, Mazurkiewicz JE et al. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med 1993; 122: 658-66.
47. 47 McMichael AJ, Pilch JR, Galfre G et al. A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol 1979; 9: 205-10.
48. 48 Wolff K, Stingl G. The Langerhans cell. J Invest Dermatol 1983; 80: 17-21S.
49. 49 Murata M, Kubota Y, Tanaka T et al. Effect of ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells. Leukemia 1994; 8: 2188-93.
50. 50 Bos JD, Zonneveld I, Das PK et al. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 1987; 88: 569-73.
51. 51 Schwarting R, Gerdes J, Ziegler A, Stein H. Immunoprecipitation of the interleukin-2 receptor from Hodgkin's disease derived cell lines by monoclonal antibodies. Hematol Oncol 1987; 5: 57-64.
52. 52 Spetz AL, Strominger J, Groh Spies V. T cell subsets in normal human epidermis. Am J Pathol 1996; 149: 665-74.
53. 53 Hill S, Milla PJ, Ciampolillo A et al. LFA-1 and ICAM-1 molecule expression in jejunal mucosa from children with autoimmune enteropathy. Autoimmunity 1992; 13: 233-41.
54. 54 van de Stolpe A, van der Saag PT. Intercellular adhesion molecule-1. J Mol Med 1996; 74: 13-33.
55. 55 Rosner K, Ross C, Karlsmark T et al. Immunohistochemical characterization of the cutaneous cellular infiltrate in different areas of chronic leg ulcers. APMIS 1995; 103: 293-9.
56. 56 Tong Y, Tucker SB. Normal human skin lymphocytic and Langerhans' cell responses to intradermal interferon alpha-2 beta injections. Am J Med Sci 1993; 306: 23-7.
57. 57 Weber-Matthiesen K, Sterry W. Organization of the monocyte/ macrophage system of normal human skin. J Invest Dermatol 1990; 95: 83-9.
58. 58 Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 1995; 14: 1129-35.
59. 59 Groh V, Porcelli S, Fabbi M et al. Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med 1989; 169: 1277-94.
60. 60 Foster CA, Stingl G. T cell receptor gamma/delta-bearing cells in the epidermis. Curr Probl Dermatol 1990; 19: 9-16.
61. 61 Odum N, Ledbetter JA, Martin P et al. Homotypic aggregation of human cell lines by HLA class II-, class Ia-and HLA-G-specific monoclonal antibodies. Eur J Immunol 1991; 21: 2121-31.
62. 62 Dohr GA, Motter W, Leitinger S et al. Lack of expression of HLA class I and class II molecules on the human oocyte. J Immunol 1987; 138: 3766-70 [published erratum appears in J Immunol 1987; 139: 3550].
63. 63 Davis AL, McKenzie JL, Hart DN. HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells. Immunology 1988; 65: 573-81.